Literature DB >> 21537668

Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae.

Priscila A M Nakamura1, Rôde Beatriz B Schuab, Felipe P G Neves, Cláudio F A Pereira, Geraldo R de Paula, Rosana R Barros.   

Abstract

In this study, 100 clinical isolates of Streptococcus agalactiae recovered from genitourinary tract specimens of non-pregnant individuals living in Rio de Janeiro were submitted for antimicrobial susceptibility testing, detection of macrolide resistance genes and evaluation of the genetic diversity of erythromycin-resistant isolates. By agar diffusion method, all isolates were susceptible to ceftazidime, penicillin and vancomycin. Isolates were resistant to levofloxacin (1%), clindamycin (5%), erythromycin (11%) and tetracycline (83%) and were intermediated to erythromycin (4%) and tetracycline (6%). Erythromycin-resistant and intermediated isolates presented the following phenotypes: M (n = 3), constitutive macrolide-lincosamide-streptogramin B (MLS B, n = 5) and inductive MLS B (n = 7). Determinants of macrolide resistance genes, erm and mef, were detected in isolates presenting MLS B and M phenotypes, respectively. Randomly amplified polymorphic DNA profiles of erythromycin-resistant isolates were clustered into two major groups of similarity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537668     DOI: 10.1590/s0074-02762011000200001

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  10 in total

1.  Molecular characterization of Streptococcus agalactiae isolated from pregnant women and newborns at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Mucheye Gizachew; Moges Tiruneh; Feleke Moges; Mulat Adefris; Zemene Tigabu; Belay Tessema
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

Review 2.  Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.

Authors:  Cilicia S do Nascimento; Nayara F B Dos Santos; Rita C C Ferreira; Carla R Taddei
Journal:  Braz J Microbiol       Date:  2019-08-20       Impact factor: 2.476

3.  Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants.

Authors:  Eliane Saori Otaguiri; Ana Elisa Belotto Morguette; Eliandro Reis Tavares; Pollyanna Myrella Capela dos Santos; Alexandre Tadachi Morey; Juscélio Donizete Cardoso; Márcia Regina Eches Perugini; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  BMC Microbiol       Date:  2013-12-21       Impact factor: 3.605

4.  Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.

Authors:  Vanusa G Dutra; Valéria M N Alves; André N Olendzki; Cicero A G Dias; Alessandra F A de Bastos; Gianni O Santos; Efigênia L T de Amorin; Meireille  B Sousa; Rosemary Santos; Patricia C S Ribeiro; Cleuber F Fontes; Marco Andrey; Kedma Magalhães; Ana A Araujo; Lilian F Paffadore; Camila Marconi; Eddie F C Murta; Paulo C Fernandes; Maria S G Raddi; Penélope S Marinho; Rita B G Bornia; Jussara K Palmeiro; Libera M Dalla-Costa; Tatiana C A Pinto; Ana Caroline N Botelho; Lúcia M Teixeira; Sérgio Eduardo L Fracalanzza
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

5.  Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.

Authors:  Maria del Pilar Crespo-Ortiz; Claudia Rocio Castañeda-Ramirez; Monica Recalde-Bolaños; Juan Diego Vélez-Londoño
Journal:  BMC Infect Dis       Date:  2014-08-03       Impact factor: 3.090

6.  Validation of the content of the prevention protocol for early sepsis caused by Streptococcus agalactiaein newborns.

Authors:  Fabiana Alves da Silva; Cláudia Fernanda de Lacerda Vidal; Ednaldo Cavalcante de Araújo
Journal:  Rev Lat Am Enfermagem       Date:  2015 Jul-Aug

7.  Evaluation of the Results of Group B Streptococcus Screening by MALDI-TOF MS among Pregnant Women in a Hungarian Hospital.

Authors:  Marianna Ábrók; Petra Tigyi; Markus Kostrzewa; Katalin Burián; Judit Deák
Journal:  Pathogens       Date:  2019-12-18

8.  Antibiotic Resistance and Molecular Epidemiological Characteristics of Streptococcus agalactiae Isolated from Pregnant Women in Guangzhou, South China.

Authors:  Zhaomin Cheng; Pinghua Qu; Peifeng Ke; Xiaohan Yang; Qiang Zhou; Kai Lan; Min He; Nannan Cao; Sheng Qin; Xianzhang Huang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-04-30       Impact factor: 2.471

9.  Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.

Authors:  Musa Mohammed Ali; Yimtubezinash Woldeamanuel; Daniel Asrat; Demissie Assegu Fenta; Bernard Beall; Stephanie Schrag; Lesley McGee
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090

10.  Distribution of serotypes and evaluation of antimicrobial susceptibility among human and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006.

Authors:  Tatiana Castro Abreu Pinto; Natália Silva Costa; Aline Rosa Vianna Souza; Ligia Guedes da Silva; Ana Beatriz de Almeida Corrêa; Flavio Gimenis Fernandes; Ivi Cristina Menezes Oliveira; Marcos Corrêa de Mattos; Alexandre Soares Rosado; Leslie Claude Benchetrit
Journal:  Braz J Infect Dis       Date:  2013-02-28       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.